Heterocyclic compounds and uses thereof
US6989451B2 · kind B2 · utility
18Cited by
7References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2003 |
| Grant date | Jan 24, 2006 |
| Priority date | — |
| Expiry date | Jun 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Substituted isothiazole compounds and compositions are provided, wherein particularly preferred compositions and methods are directed towards inhibition of various protein kinases (especially MEK and/or ERK). Consequently, particularly preferred methods include treatment of diseases associated with abnormality in MEK and/or ERK function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.